Rentokil Initial plc Files 2024 Interim Results

TL;DR

Rentokil Initial plc dropped its 2024 interim results on 7/25. Check it out.

AI Summary

Rentokil Initial plc filed a Form 6-K on July 25, 2024, reporting its 2024 interim results. The filing provides an update on the company's performance and financial position for the period. The company is headquartered at Compass House, Manor Royal, Crawley, West Sussex, RH10 9PY, United Kingdom.

Why It Matters

This filing provides investors with crucial, up-to-date financial information on Rentokil Initial plc's performance, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine interim results filing, not indicating any immediate or significant new risks.

Key Players & Entities

• Rentokil Initial plc (company) — Filer of the report
• 001-41524 (dollar_amount) — SEC File Number
• 20240725 (date) — Filing date

FAQ

Key Financial Figures

• $25m — tion. To harness the growth opportunity $25m additional investment committed (c.$50m
• $50m — $25m additional investment committed (c.$50m in total), including c.$15m P&L spend i
• $15m — ommitted (c.$50m in total), including c.$15m P&L spend in FY 24   ●
• $162m — th first branch integrations advancing. $162m gross and $105m net cost synergies deli
• $105m — integrations advancing. $162m gross and $105m net cost synergies delivered to date: $
• $58m — m net cost synergies delivered to date: $58m gross and $23m net in H1 24  
• $23m — rgies delivered to date: $58m gross and $23m net in H1 24   ● &#xA
• $21m —   In H1, we spent approximately $21m of the $25m allocated to target growth
• $25 — into growth by committing an additional $25m, including c.$15m P&L spend in FY 24.
• $27m — tention on a full year basis delivers c.$27m in Organic Revenue. In H1 we launched a
• $65m — erating Profit in 2024 of approximately $65m and $4m respectively. This closure has
• $4m — rofit in 2024 of approximately $65m and $4m respectively. This closure has been tre

Filing Documents

• rentokilinitialplc.htm (6-K) — 1132KB
• 0001654954-24-009374.txt ( ) — 1133KB

business

business   Financial Results 1 AER   CER £m H1 2024£m H1 2023£m Change% H1 2024£m H1 2023£m Change% Revenue 2,706 2,671 1.3%   2,756 2,650 4.0% Adjusted EBITDA 611 602 1.5%         Adjusted Operating Profit 445 437 1.9%   455 434 4.7% Adjusted Profit before Tax 383 377 1.8%   394 371 6.1% Free Cash Flow 172 229 (24.9%)         Diluted Adjusted EPS   11.60p 11.41p                           Statutory Results               Revenue 2,706 2,671 1.3%         Operating Profit 321 304 5.6%         Profit before Tax 253 240 5.6%         EPS 7.78p 7.35p           Dividend Per Share 3.16p 2.75p               Highlights  (Unless otherwise stated, all financials are presented at constant exchange rates)   ●   Revenue up 4.0% and up 1.3% on a statutory basis. Organic Revenue growth of 2.8%   ●   Early progress in North America growth plan with 50bps quarter-on-quarter improvement in Pest Control services organic growth (1.0% in Q1, 1.5% in Q2). Positive movement in leading indicators:     -   Stronger North American sales colleague retention, up c.4ppts     -   Better Terminix brand favourability from our advertising campaign that delivered 685m views     -   Improved inbound digital lead flow volumes, up each month in Q2     -   Increased technician sales leads participation, up fro

financial statements

financial statements. AER - actual exchange rates; CER - constant 2023 exchange rates This announcement contains statements that are, or may be, forward-looking regarding the Group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements.

Forward-looking statements speak only as of the date they are made

Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure Guidance and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.       Summary of financial performance (at CER)   Regional Performance   Revenue   Adjusted Operating Profit   H1 2024£m H1 2023£m Change% H1 2024£m H1 2023£m Change% North America 1,662 1,643 1.1%   310 304 1.8%  Pest Control 1,614 1,598 1.0%   304 300 1.1%  Hygiene & Wellbeing 48 45 7.6%   6 4 51.5%                 Europe (inc LATAM) 562 525 7.0%   106 97 9.1%  Pest Control 269 249 8.0%   61 57 6.9%  Hygiene & Wellbeing 177 168 5.2%   25 22 14.4%  France Workwear 116 108 7.5%   20 18 9.4%                 UK & Sub Saharan Africa 213 189 13.2%   49 45 9.3%  Pest Control 101 96 5.2%   26 25 3.6%  Hygiene & Wellbeing 112 93 21.4%   23 20 16.6%              

View Full Filing

View this 6-K filing on SEC EDGAR